Form 4: InMed Pharmaceuticals Executive Reports Stock Option Conversion
SEC Form 4 Filing
Alexandra Diane Janet Mancini, Senior VP of Clinical and Regulatory Affairs at InMed Pharmaceuticals, reports converting employee stock options into common shares.
Summary
- Alexandra Diane Janet Mancini, a Senior VP at InMed Pharmaceuticals, filed a Form 4 detailing changes in beneficial ownership.
- On January 21, 2024, Mancini converted employee stock options into 121 common shares.
- The exercise price was converted from C$420.75 to $312.73 USD using an exchange rate of C$1.3454 = $US1.00.
- Following the transaction, Mancini directly owns 52,485 common shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, indicating a standard transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 01/21/2019 | Date exercisable for Employee Stock Option |
| 01/21/2024 | Date of transaction and expiration of Employee Stock Option |
| 03/05/2024 | Date of signature for the report |
Keywords
Form 4, InMed Pharmaceuticals, Stock Options, Beneficial Ownership, Alexandra Diane Janet Mancini, INM, Conversion
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.